Fritextsökning
Innehållstyper
-
IVDR Reality Check: Are We Moving Fast Enough?
As of February 2025, around 1,500 IVDR certificates have been issued. But if an estimated 18,700 devices still need certification before the 2029 deadline, then...
-
Reduced heat transfer to the media with media-separated valves
In laboratory automation, many liquids are used that react sensitively to heat. One possible factor for the transfer of heat to the fluid are media-separated so...
-
100 years of Festo
The spirit of invention is deeply rooted in our corporate culture. Since our foundation, we have been setting benchmarks by developing innovative solutions that...
-
Improving Nano-Structured Surfaces for Implants with Scanning Electron Microscopy
Promimic, a Swedish company specializing in the development and marketing of nano-structured surfaces for implants, heavily relies on scanning electron microscopes.
-
Gröna satsningar ger klirr i kassan för svenska tillverkare
Allt fler svenska medelstora tillverkare ser hållbarhet som en självklar del av affären – och inte bara för att det är rätt väg framåt ur ett miljöperspektiv. E...
-
ZEISS Connected Quality: One metrology hub
The new product family ZEISS CONNECTED QUALITY is the solution for quick and secure data exchange, quality management and efficient system monitoring.
-
Scale Up Your Image Analysis
ZEISS arivis Hub for accelerated analysis and faster results.
-
Nordisk VD för ZEISS lämnar över stafettpinnen
Walther Heger, Managing Director för ZEISS Nordics sedan 28 år, har beslutat sig för att avsluta en imponerande karriär. I slutet av september kommer Walther He...
-
Introducing ZEISS arivis Pro 4.2
Your solution for advanced image analysis and visualization.
-
Cost-efficient development of laboratory devices
8 ways to optimise development costs and speed up processes
-
Scientific Solutions stärker organisationen
Mario Clementi är ny Director Pharmacovigilance and Quality Assurance på Scientific Solutions. Med en imponerande bakgrund inom farmakovigilans och mångårig erf...
-
Eternal Rye – Improving Plant Breeding Methods
User story from Martin Luther University Halle.
-
Öppen frågestund: Regulatory Opportunities for Rare Diseases/Orphan Products in US and EU
Anmäl dig till vår nästa session av Office Hours den 28 februari klockan 15:00 (svensk tid), en öppen frågestund om utveckling av särläkemedel (orphan drugs).
-
Quality Assurance for the Highest Medical Standards
Metrology Solutions for Medical Components.
-
No longer afraid of the dentist.
Teaching robot with piezo technology
-
SDS rekryterar Director Business Management
SDS Life Science rekryterar Ulrika Andersson som Director Business Management. Ulrika tillträder i rollen under augusti.
-
40,000 DNA extractions daily
It's great when things run quickly: 20 minutes per extraction process and a new plate every 2.5 minutes – the Dutch company Synchron Lab Automation, in cooperat...
-
Webinar: Medtech quality and regulatory compliance
This webinar is for you who are developing or planning to develop a medical device, combination, or borderline product. In one hour, we will discuss what you ne...
-
The fast route to a safe insulin pen
Diabetes is on the rise worldwide with around ten million people developing the disease every year. Demand for insulin pens allowing patients to self-medicate i...
-
Webinar: What is Regulatory Affairs?
This webinar is intended for those who work within the life science sector and would like to gain a general understanding of regulatory affairs for human medicinal products.
-
Trends and overview: ELRIG "Robotics and Automation"
Laboratories on the way to end-to-end automation: Robotics, artificial intelligence and automation technology boosted by pandemic
-
Automated opening and closing of sample vials
From technical requirements to a suitable solution
-
Collaboration in laboratory automation
The Dutch company Synchron Lab Automation developed an automated DNA extraction system with high throughput, working very closely together with Festo. As a resu...
-
Nordic Regulatory experts: Improving biotech chances of Succ
Why is it that so many biotech companies fail? And what are the tools needed to change that fact?